Skip to content
Log in
Sponsored Design Multi-Agent AI Systems Using MCP and A2A: Engineer your own Pyt Design Multi-Agent AI Systems Using MCP and A2A: Engineer your own Pyt
Open access

Oncogenic Mutations and Tumor Microenvironment Alterations in Diffuse Large B‐Cell Lymphoma With Bulky Disease

Yu-Qing Wang Yue Wang Zhi-Shan Du Xin-Yun Huang Yan Dong Shuang Tian D. Fu Shu Cheng Li Wang Peng-Peng Xu Sheng-Jin Fan Shu-Ye Wang
Sep 2026 · Cancer Medicine · Vol 15 · 0 citations · 54 references
Medicine

TL;DR

The aim of this study was to investigate the influence of oncogenic mutations and tumor microenvironment alterations on bulky disease in DLBCL.

Abstract

Bulky disease represents a clinically aggressive subset of diffuse large B‐cell lymphoma (DLBCL) associated with adverse clinical outcomes. The aim of this study was to investigate the influence of oncogenic mutations and tumor microenvironment alterations on bulky disease in DLBCL.

DOI PubMed Semantic Scholar
Read PDF

Similar papers

Open access Aug 2026

Clinical outcomes associated with NPM1 mutations in newly diagnosed acute myeloid leukemia

Nucleophosmin 1‐mutated (NPM1mt) acute myeloid leukemia (AML) is associated with a relatively favorable prognosis though long‐term outcomes remain suboptimal without clear predictors identified by therapy.

Aziz Farhat, Georgina El Hajjar, H. Kantarjian et al. · 1 citation
Open access Sep 2026

Clinical Outcomes, Treatment Patterns, and Molecular Heterogeneity of TFE3‐Rearranged Renal Cell Carcinoma: A Multicenter Real‐World Study

TFE3‐rearranged renal cell carcinoma (TFE3‐rRCC) is uncommon and encompasses biologically diverse tumors, while evidence to guide systemic treatment remains sparse. We examined clinical outcomes, treatment patterns, and molecular features in a multicenter real‐world cohort.

Shu-Xuan Zhu, Si-Qi Zhou, Xi Tian et al. · 0 citations
Case report Open access Sep 2026

A POLE P286R‐Mutated Hepatoid Adenocarcinoma of the Lung Showing Substantial Response to Immune Checkpoint Inhibition

Hepatoid adenocarcinoma of the lung (HAL) is a rare form of lung cancer with histological and morphological properties of hepatocellular carcinoma, characterized by an aggressive course of the disease and unfavorable prognosis. Given the rarity of the pathology and the lack of unambiguous therapeutic protocols, descrip...

A. Chernev, A. Kaurtseva, R. Abasov et al. · 0 citations
Open access Sep 2026

DDX41 mutations establish a separate entity in acute myeloid leukemia with distinct survival outcomes

Recurrent germline variants in DDX41 represent the most common inherited predisposition to adult myeloid neoplasms, occurring in approximately 3% – 5% of patients with acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS). 1,2 Clinically, patients with DDX41 ‐ mutated AML are typically older at diagnosis, pred...

Carolin Seeling, Maral Saadati, D. Späth et al. · 0 citations
Open access Sep 2026

EZH2 expression in diffuse large B-cell lymphoma: clinicopathological associations and relationship with survival

Purpose: Enhancer of zeste homolog 2 (EZH2) is an epigenetic regulator implicated in the pathogenesis of diffuse large B-cell lymphoma, but the prognostic value of its protein expression is uncertain. We evaluated EZH2 expression and its associations with clinicopathological features and survival.Materials and Methods:...

Mehmet Mutlu Kıdı, Mehmet Turker, Sedat Biter et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.